Wednesday, July 8, 2026

pharma · Advanced Solid Tumor · Sarcoma · PRLD

Prelude Therapeutics

News and analysis for Prelude Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

175 Innovation Boulevard, Wilmington, DE 19805, US HQ
2016 Founded
111 Employees
Public company Type
PRLD · NYSE Ticker
Company details
Status
Public
HQ
175 Innovation Boulevard, Wilmington, DE 19805, US
Founded
2016
Employees
111
Programs
13
Drugs
5
Patents
16
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Prelude Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Prelude Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Prelude Therapeutics yet.

Back to company overview →